Immunotherapy engagement in pancreatic adenocarcinoma: Provisional results of iLSTA study- Durvalumab, LSTA1 (certepetide), gemcitabine, and nab-paclitaxel for locally advanced pancreatic ductal adenocarcinoma.

被引：0

作者：

Dean, Andrew Peter

Johansson, Mikael

Yusoff, Ian

Rao, Samarth

Sparrow, Susan

Kumarasinghe, Priyanthi

Navadgi, Suresh

Watanabe, Yuki

Webber, Laurence

Grew, Jenny

Fitzgerald, Shane

Comito, Olivia Rose

机构：

[1] St John God Subiaco Hosp, Subiaco, Australia

[2] Dept Upper GI Surg, Nedlands, Australia

[3] Sir Charles Gairdner Hosp, Nedlands, Australia

[4] Australian Clin Labs, Subiaco, Australia

来源：

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.746

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1